NRX Pharmaceuticals (NRXP) Current Taxes (2018 - 2020)

NRX Pharmaceuticals (NRXP) has reported Current Taxes for 3 consecutive years, with $3145.0 the latest figure, recorded in Q1 2020.

• On a quarterly basis, Current Taxes fell 93.45% year-over-year to $3145.0 in Q1 2020; TTM through Mar 2020 was $3145.0, a 93.45% decrease from a year earlier, with the FY2018 full-year figure at $16311.0, changed N/A from the prior year.
• Current Taxes was $3145.0 for Q1 2020 at NRX Pharmaceuticals, down from $104439.0 in the prior quarter.
• Over five years, Current Taxes peaked at $104439.0 in Q3 2019 and troughed at $3145.0 in Q1 2020.
• A 3-year average of $40731.9 and a median of $32169.0 in 2018 frame the typical range for Current Taxes.
• Across the five-year window, Current Taxes soared 1067.12% in 2019 and slumped 93.45% in 2020, its largest moves.
• Over 3 years, Current Taxes stood at $16311.0 in 2018, then soared by 540.3% to $104439.0 in 2019, then slumped by 96.99% to $3145.0 in 2020.
• The last three Current Taxes figures came in at $3145.0 (Q1 2020), $104439.0 (Q3 2019), and $88703.0 (Q2 2019), per Business Quant data.